CN1724544A - Extraction of plasmalogen kind anticancer medicine from animal liver - Google Patents
Extraction of plasmalogen kind anticancer medicine from animal liver Download PDFInfo
- Publication number
- CN1724544A CN1724544A CN 200410054841 CN200410054841A CN1724544A CN 1724544 A CN1724544 A CN 1724544A CN 200410054841 CN200410054841 CN 200410054841 CN 200410054841 A CN200410054841 A CN 200410054841A CN 1724544 A CN1724544 A CN 1724544A
- Authority
- CN
- China
- Prior art keywords
- plasmalogen
- phosphatide
- extraction
- acetal
- acetal phosphatide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to process for preparing acetal phosphatide anti-cancer medicament from animal livers, especially acetal phosphatide medicament for effectively inhibiting hepatic carcinoma, wherein the preparation comprises extracting total fat with Floch method, disintegrating acetal phosphatide with non-acetal phosphatide with different expansion systems. The beneficial effects of the invention include simple extraction process, high purity of acetal phosphatide and improved quality.
Description
Affiliated technical field: the present invention relates to a kind of plasmalogen cancer therapy drug that from animal livers, extracts, especially can effectively suppress the plasmalogen medicine of liver cancer.
Background technology: at present, the medicine of state's internal therapy liver cancer is many starts with from immunotherapy, bacille Calmette-Guerin vaccine, Interferon, rabbit etc., and the chemicals of treatment liver cancer only be suitable for more than 80% can not excision in, patients with terminal.Treatment by Chinese herbs liver cancer is also based on the enhancing immunization of cell, but curative ratio is extremely low.
Plasmalogen is a kind of glyceryl phosphatide that contains the alkene ehter bond, the plasmalogen analogue that existing report is pointed out synthetic is to tumour cell cytotoxicity selectively, but also only stays on the experiment in vitro level, and, synthetic plasmalogen analogue technical matters complexity, required cost is higher.
Summary of the invention: the present invention extracts plasmalogen in order to overcome synthetic plasmalogen technical matters complexity, the higher deficiency of required cost from animal livers.The technical scheme that is adopted is: the Floch method is extracted total fat, and different expansion systems are separated plasmalogen and non-plasmalogen.
The invention has the beneficial effects as follows that extraction process is simple, draw materials extensively that the plasmalogen purity that obtains is good, quality is high.Body is interior, experiment in vitro shows that this plasmalogen medicament has the obvious suppression effect to liver cancer cell.
Claims (3)
1. a plasmalogen cancer therapy drug that extracts from animal livers is characterized in that: different expansion systems separation plasmalogens and non-plasmalogen.
2. according to claim 1, it is characterized in that: the different systems that launch.
3. according to claim 1, it is characterized in that: separate plasmalogen and non-plasmalogen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410054841 CN1724544A (en) | 2004-07-25 | 2004-07-25 | Extraction of plasmalogen kind anticancer medicine from animal liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410054841 CN1724544A (en) | 2004-07-25 | 2004-07-25 | Extraction of plasmalogen kind anticancer medicine from animal liver |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1724544A true CN1724544A (en) | 2006-01-25 |
Family
ID=35924187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410054841 Pending CN1724544A (en) | 2004-07-25 | 2004-07-25 | Extraction of plasmalogen kind anticancer medicine from animal liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1724544A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022237632A1 (en) * | 2021-05-11 | 2022-11-17 | 江南大学 | Application of microorganism-derived plasmalogen in treatment of colon cancer |
-
2004
- 2004-07-25 CN CN 200410054841 patent/CN1724544A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022237632A1 (en) * | 2021-05-11 | 2022-11-17 | 江南大学 | Application of microorganism-derived plasmalogen in treatment of colon cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wachtel-Galor et al. | Ganoderma lucidum (Lingzhi or Reishi): a medicinal mushroom | |
| Matsuda et al. | Suppressive effect of Juzen-Taiho-To on lung metastasis of B16 melanoma cells in vivo | |
| CA2507262A1 (en) | Pharmaceutical composition containing bakuchiol for treating female osteoporosis | |
| Badalyan et al. | Mushrooms as promising therapeutic resources: review and future perspectives | |
| CN101623309A (en) | Technology for extracting Chinese actinidia root antitumor active site | |
| Liu et al. | Pharmacological and anti-tumor activities of Ganoderma spores processed by top-down approaches | |
| CN106038788B (en) | Compatible composition for reducing toxicity and preserving effects of gelsemium elegans and compatibility method thereof | |
| CN1724544A (en) | Extraction of plasmalogen kind anticancer medicine from animal liver | |
| TW201004634A (en) | A drug comprising antrodia camphorata compositions for topical and acupoint administration applications | |
| CN103202869A (en) | Traditional chinese medicine composition and preparation method thereof | |
| Arora | Cordyceps sinensis (berk.) sacc.-an entomophagous medicinal fungus-a review | |
| CN103182006A (en) | Traditional chinese medicine composition and preparation method thereof | |
| CN103340962A (en) | Natural pharmaceutical composition, and preparation method and application thereof | |
| CA2507259A1 (en) | Pharmaceutical composition containing bakuchiol for treating female breast cancer | |
| CN109394799B (en) | Natural pharmaceutical composition containing ganoderma lucidum extract and preparation method and application thereof | |
| Levin et al. | Medicinal properties of Antrodia camphorata-a review. | |
| CN101371857A (en) | Composite medicament for inhibiting tumor and preparation method thereof as well as technique field | |
| CN103223040A (en) | Traditional chinese medicine composition | |
| WO2007020222A3 (en) | Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof | |
| KR102644398B1 (en) | Immuno Anticancer Composition Containing Rhus Veniciflua Strokes Extract And Cytokine Induced Killer Cells | |
| EP2402021A1 (en) | Pharmaceutical composition for treating or releiving inflammatory bowel disease | |
| CN103800351A (en) | Pharmaceutical application of akebin E | |
| CN103223044A (en) | Traditional Chinese medicinal composition and its preparation method | |
| CN102949384A (en) | Application of coffee acid 3, 4-dihydroxy benzene ethyl ester to preparation of antitumor drug | |
| TWI654985B (en) | A use of an extract of a formula including a fruit body of antrodia cinnamomea in the manufacture of a medicament for the treatment of hepatitis b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |